RA Topic Center Upper Left Box
Author(s):
Biologics and DMARDs are hailed as miracles and almost-cures for rheumatoid arthritis, if you can catch the patient quickly enough. But Jon Lampa MD of Karolinska Hospital in Sweden has noticed that many studies use inflammation, not pain relief, as their criterion for success.
WHEN RA TREATMENT
FALLS SHORT
Biologics and DMARDs are hailed as miracles and almost-cures for rheumatoid arthritis, if you can catch the patient quickly enough. But Jon Lampa MD of Karolinska Hospital in Sweden has noticed that many studies use inflammation, not pain relief, as their criterion for success.
So: How many patients "adequately" treated for RA continue to suffer pain nonetheless? He and his coworkers decided to look at the magnitude of the problem, with noteworthy results.
It's time to pay more attention to pain from baseline, he says in this brief video, and to find ways to do something about it when the best modern treatments don't.
See Big Flaw in RA Treatment Success Record: Remaining Pain.
